8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001564590-21-034792
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading abio-8k_20210628.htm…